Tonix Pharmaceuticals Holding Corp. Quarterly Cost of Revenue in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Cost of Revenue history and growth rate from Q3 2023 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Cost of Revenue for the quarter ending September 30, 2024 was $1.56M, a 34.5% decline year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.56M -$819K -34.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.37M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $1.66M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q3 2023 $2.37M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.